Zhirui Liu
Overview
Explore the profile of Zhirui Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li X, Yu B, Li H, Liu Z, Fu X, Jiao P, et al.
Drug Des Devel Ther
. 2025 Feb;
19:683-701.
PMID: 39906698
Background: Biofilm formation often represents significant challenges in managing of bloodstream infections associated with catheter use. Objective: Antimicrobial lock therapy serves as an adjunctive treatment for catheter-related infections, effectively eradicating...
2.
Zhang C, Yuan Y, Xia Q, Wang J, Xu K, Gong Z, et al.
Adv Sci (Weinh)
. 2025 Jan;
12(9):e2415902.
PMID: 39792782
Small molecules as nanomedicine carriers offer advantages in drug loading and preparation. Selecting effective small molecules for stable nanomedicines is challenging. This study used artificial intelligence (AI) to screen drug...
3.
Cheng S, Li Y, Sun X, Liu Z, Guo L, Wu J, et al.
Front Immunol
. 2024 Dec;
15:1508985.
PMID: 39712019
Acute lung injury (ALI) is a prevalent and critical complication of sepsis, marked by high incidence and mortality rates, with its pathogenesis still not being fully elucidated. Recent research has...
4.
Yao Y, Zhou Z, Wang X, Liu Z, Zhai Y, Chi X, et al.
Cell Genom
. 2024 Jun;
4(7):100583.
PMID: 38889719
CRISPR mutagenesis screens conducted with SpCas9 and other nucleases have identified certain cis-regulatory elements and genetic variants but at a limited resolution due to the absence of protospacer adjacent motif...
5.
Xiong Y, Liu Z, Wang Y, Wang J, Zhou X, Li X
Pharmaceutics
. 2024 May;
16(5).
PMID: 38794282
In situ depot gel is a type of polymeric long-acting injectable (pLAI) drug delivery system; compared to microsphere technology, its preparation process is simpler and more conducive to industrialization. To...
6.
Hu Y, Shi T, Xu Z, Zhang M, Yang J, Liu Z, et al.
Aging (Albany NY)
. 2024 Apr;
16(8):7357-7386.
PMID: 38656892
Background: Heart failure (HF) has been reported to affect cerebral cortex structure, but the underlying cause has not been determined. This study used Mendelian randomization (MR) to reveal the causal...
7.
Zhang Q, Hu C, Feng J, Long H, Wang Y, Wang P, et al.
J Control Release
. 2024 Mar;
369:12-24.
PMID: 38508526
Neutrophil membrane-coated nanoparticles (NM-NPs) are nanomedicines with traits of mimicking the surface properties and functions of neutrophils, which are the most abundant type of white blood cells in the human...
8.
Wang X, Yang J, Lu C, Hu Y, Xu Z, Wan Q, et al.
Drug Des Devel Ther
. 2024 Mar;
18:781-799.
PMID: 38500692
Purpose: This study aimed to elucidate the protective mechanism of Traditional Chinese Medicine (TCM) Qifu Yixin formula (QFYXF) to improve heart failure (HF) by promoting β-arrestin2 (β-arr2)-mediated SERCA2a SUMOylation. Materials...
9.
Cheng L, Liu Z, Yu M, Lin L, Xiong L, Dai Q
J Clin Pharmacol
. 2023 Nov;
64(4):461-468.
PMID: 37910022
Hypokalemia and hyponatremia are common but easily ignored adverse events in treatment with voriconazole (VCZ) that can lead to serious consequences. We intend to investigate the incidence of VCZ-induced hypokalemia...
10.
Cheng L, Luo M, Guo Y, Fan Y, Wang P, Zhou G, et al.
Front Pharmacol
. 2023 Oct;
14:1248331.
PMID: 37869746
The plasma concentrations of the four most commonly used first-line anti-tuberculosis (TB) drugs, isoniazid (INH), rifampicin (RMP), ethambutol (EMB), and pyrazinamide (PZA), are often not within the therapeutic range. Insufficient...